Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aac4a747e60a2949ac458ccdbb76fdea |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G63-08 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-593 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-148 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-0029 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G63-912 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
filingDate |
2008-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_306a212ff074458afe717a5b3d5e167d |
publicationDate |
2009-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2009073811-A |
titleOfInvention |
Coating using antithrombotic conjugate |
abstract |
A material for application to at least a portion of the surface of an article or for implantation in an article is provided. A biodegradable antithrombotic conjugate having heparin and other antithrombogenic moieties is introduced as a side chain into the backbone of the polymer modified by click chemistry. Various bioabsorbable monomers and dimers, such as valerolactone, can be used for monomer derivatization, homo- and co-polymerization, and conjugation with biologically active molecules by click chemistry. A coating comprising a biocompatible and bioabsorbable polymer antithrombotic conjugate is applied to at least a portion of the implantable device to prevent or reduce the formation of thrombosis on the surface of the implantable device. Is done. The first or bottom layer of the coating is prepared by mixing the polymeric material and the biologically active agent with a solvent, thereby forming a homogeneous solution. [Selection] Figure 4 |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011019918-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015164553-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015507646-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017504573-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016534210-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012502678-A |
priorityDate |
2007-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |